BMY
BMY
Bristol-Myers Squibb Company
$56.64
+$0.25 (+0.44%)
Mkt Cap: $115.66B
Home / BMY / Financial Statements

Bristol-Myers Squibb Company (BMY) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$48.48B
$48.19B ↓0.2%
$48.30B ↑7.3%
$45.01B ↓2.5%
$46.16B ↓0.5%
$46.38B
Cost of Revenue
$15.15B
$15.59B ↓25.3%
$20.87B ↑6.2%
$19.65B ↓0.1%
$19.67B ↑0.2%
$19.62B
Gross Profit
$33.33B
$32.60B ↑18.8%
$27.43B ↑8.2%
$25.36B ↓4.3%
$26.49B ↓1.0%
$26.76B
R&D Expenses
$10.03B
$9.61B ↓1.7%
$9.78B ↑6.2%
$9.21B ↓2.2%
$9.41B ↓1.3%
$9.53B
SG&A Expenses
$7.28B
$7.24B ↓7.9%
$7.87B ↑2.4%
$7.68B ↓1.7%
$7.81B ↑1.6%
$7.69B
Operating Income
$12.45B
$12.70B ↑31.5%
$9.66B ↑14.0%
$8.47B ↓8.6%
$9.27B ↓2.8%
$9.54B
Interest Expense
$1.02B
$1.51B ↓22.4%
$1.95B ↑67.0%
$1.17B ↓5.4%
$1.23B ↓7.6%
$1.33B
Income Tax
$2.32B
$2.27B ↑310.1%
$554.00M ↑38.5%
$400.00M ↓70.8%
$1.37B ↑26.2%
$1.08B
Net Income
$7.28B
$7.05B ↑178.8%
-$8.95B ↓211.5%
$8.03B ↑26.8%
$6.33B ↓9.5%
$6.99B
EBITDA
$13.78B
$14.54B ↑359.1%
$3.17B ↓83.6%
$19.37B ↑0.8%
$19.22B ↓4.5%
$20.12B
EPS
3.56
3.45 ↑178.2%
-4.41 ↓214.2%
3.86 ↑30.8%
2.95 ↓5.4%
3.12
Shares Out (Diluted)
8.16B
2.04B ↑0.7%
2.03B ↓2.5%
2.08B ↓3.2%
2.15B ↓4.4%
2.25B